Abstract
This research service was constructed to provide an overview of trends, business models and selected areas of opportunity in specialty pharmaceuticals. Market forecasts are provided at the total market level for selected disease markets: Pulmonary Arterial Hypertension, Opioid and Non-Opioid Pain Management, Multiple Sclerosis, and Alzheimer' s disease. Challenges and trends for specialty pharma as well as the pharmaceutical and biotechnology industry are discussed as well as future opportunities and market landscape.
Table of Contents
1 U.S. SPECIALTY PHARMACEUTICALS - OVERVIEW AND TRENDS
- Introduction
- Title
- Disclaimer
- Certification
- Research Scope and Methodology
- Table of Contents
- Introduction
- Current State of Pharma
- Industry Challenges
- Specialty Pharmaceuticals
- Importance of Specialty Pharma
- Business Models
- Business Models
- Business Model Development
- Market Structure
- Business Model Adoption
- Importance of Drug Delivery
- Changing Industry Sales Paradigms
- Specialty Pharma - Operational Focus
- Selected Disease Sectors
- Selected Disease Areas
- Specialty Products - Market Targets
- Pulmonary Arterial Hypertension
- PAH Revenue Forecasts
- Opioid and Non-opioid Pain Management
- Opioid and Non-opioid Pain Management Revenue Forecasts
- Multiple Sclerosis
- MS Revenue Forecasts
- Alzheimer' s Disease
- Alzheimer' s Disease Revenue Forecasts
- Trends in Specialty Pharma
- Trends in Specialty Pharma
- Key Drivers
- Challenges within Specialty Pharma
- Market Trends
- Conclusion
- Conclusion Introduction
- Conclusion
- Opportunities in Specialty Pharma
- Future Competitive Landscape
- Pharmaceutical & Biotechnology Industry Trends
- Appendix
- About Frost & Sullivan
